Jordi Rovira
Research group
- Nephrology and transplantation (LENIT) Accredited researcher (R3A)
Featured publications
-
Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-Kidney Transplantation
Authors:Reference: Transplantation 2022. -
B Cell-Derived Extracellular Vesicles Reveal Residual B Cell Activity in Kidney Graft Recipients Undergoing Pre-Transplant Desensitization
Authors:Reference: Frontiers In Medicine 2021. -
Influence of Persistent Inflammation in Follow-Up Biopsies After Antibody-Mediated Rejection in Kidney Transplantation
Authors:Reference: Frontiers In Medicine 2021. -
Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
Authors:Reference: American Journal Of Transplantation 2021. -
The impact of functional delayed graft function in the modern era of kidney transplantation
Authors:Reference: Transplant International 2021. -
Kidney graft outcomes in high immunological risk simultaneous liver-kidney transplants
Authors:Reference: Liver Transplantation 2020. -
Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection
Authors:Reference: Frontiers In Cell And Developmental Biology 2020. -
Inhibition of the mTOR pathway: a new mechanism of ß-cell toxicity induced by Tacrolimus
Authors:Reference: American Journal Of Transplantation 2019. -
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
Authors:Reference: Bmc Nephrology 2018. -
Tofacitinib halts progression of graft dysfunction in a rat model of mixed cellular and humoral rejection.
Authors:Reference: Transplantation 2018.
Featured Projects
-
Immunoteràpia cel•lular adoptiva pel control de la nefropatia membranosa: utilització de cèl•lules T modificades genèticament amb receptors quimèrics d’antigen
Principal investigator: Jordi Rovira JuarezFunder: Acadèmia de les Ciencies Mèdiques i de la Salut de Catalunya i de BalearsDuration: 01/06/2022 - 31/05/2023 -
Ex vivo evaluation and conditioning of kidney grafts discarded for transplantation using the normothermic perfusion machine and the use of extracellular vesicles.
Principal investigator: Antonio Alcaraz, Mireia MusqueraFunder: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Instituto de Salud Carlos IIICode: PI21/00205Duration: 01/01/2022 - 31/12/2024 -
Impact of photopheresis on the prevention of acute rejection in highly sensitized de novo kidney transplant recipients
Principal investigator: Fritz DiekmannFunder: Mallinckrodt ; IDIBAPS (Sede o evento)Duration: 01/09/2021 - 31/08/2024 -
Inmunoterapia celular adoptiva para el control del rechazo mediado por anticuerpos tras el trasplante renal: uso de células NK modificadas genéticamente con receptores quiméricos de antígeno.
Principal investigator: Eduard Palou, Fritz DiekmannFunder: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Instituto de Salud Carlos IIICode: PI20/00207Duration: 01/01/2021 - 31/12/2023 -
Caracterización fenotípica y funcional de linfocitos, monocitos y macrófagos mediante citometría de flujo del sedimento urinario en pacientes con nefritis lúpica para la predicción de enfermedad renal crónica
Principal investigator: Luis Fernando Quintana PorrasFunder: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Sociedad Espanola de NefrologiaDuration: 01/01/2021 - 31/12/2022